Asosiy kontentga oʻtish
AkademScholar

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBasetez oradaDasturchilar API
Jurnal

Clinical Lymphoma Myeloma & Leukemia

ISSN:
2152-2650
0
h-indeks
0
Iqtiboslar
26
Asarlar
0.00
2-yillik oʻrtacha iqtibos

Ishonch signallari

1 dan 3 signal mavjud

Mustaqil ijobiy signallar — yagona “predator/qonuniy” hukmi emas, balki yaqinlashuvchi tasvir.

  • DOAJ
    Maʼlumot yoʻq
    doaj.org
  • OAK roʻyxati
    Maʼlumot yoʻq
    OAK
  • Yaroqli ISSN
    Mavjud
    ISSN

Bu axborot yorligʻi, rasmiy qaror emas. Signal yoʻqligi jazo emas — masalan, mintaqaviy jurnal DOAJ'da boʻlmasligi mumkin.

Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
03581001201920212023202420252019: Nashrlar 1, Iqtiboslar 02021: Nashrlar 2, Iqtiboslar 02023: Nashrlar 10, Iqtiboslar 02024: Nashrlar 5, Iqtiboslar 02025: Nashrlar 8, Iqtiboslar 0

Nashr tarixi

035810201920212023202420252019: Nashrlar 12021: Nashrlar 22023: Nashrlar 102024: Nashrlar 52025: Nashrlar 8

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

01201920212023202420252019: h-indeks 02021: h-indeks 02023: h-indeks 02024: h-indeks 02025: h-indeks 0

Eng koʻp iqtibos qilingan asarlar

  1. The Clinical Efficacy of Chelation Therapy in Patients with Myelodysplastic Syndrome, Low Risk20190 iqtibos
  2. MDS-259: Myelodysplastic Syndrome in Uzbekistan: A Study of Prevalence20210 iqtibos
  3. Poster: MDS-259: Myelodysplastic Syndrome in Uzbekistan: A Study of Prevalence20210 iqtibos
  4. CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 iqtibos
  5. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 iqtibos
  6. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment20230 iqtibos
  7. POSTER: ALL-253 Evaluation of Aberrant Expression of CD Markers in Acute Leukemia Cells20230 iqtibos
  8. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial20230 iqtibos
  9. MDS-580 Case Report of Myelodysplastic Neoplasm (MDS) Hiding Under Immune Thrombocytopenic Purpura (ITP)20230 iqtibos
  10. POSTER: ALL-296 Results of Treatment of Children With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Low-dose Chemotherapy Without Bone Marrow Transplantation in Uzbekistan20230 iqtibos
AkademIndex'da koʻrish →